Olanzapine Substitution Effective in Triple Therapy for Carboplatin-Induced CINV
Researchers explored the effectiveness of olanzapine with granisetron and dexamethasone in patients with thoracic malignancies.
Diagnosis & Disease Information
Playing a Serious Game Facilitated Patient-Directed Approaches for CINV
Researchers explored the effectiveness of using an iPad-based, interactive game to educate first-time chemotherapy patients on prevention and self-management of CINV.
Ready-to-Dilute Liquid Formulation of Akynzeo Injection Approved
The FDA has approved a new ready-to-dilute liquid formulation of Akynzeo® injection (fosnetupitant/palonosetron; Helsinn) for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy, in combination with dexamethasone in adults.
Practical Guidance for Managing Selinexor-Associated Adverse Events
Involvement of nurses trained in the management of selinexor-associated AEs in patients with multiple myeloma is a key element of these recommendations.
Aromatherapy With Peppermint Essential Oil May Help Alleviate Nausea Associated With Chemotherapy
A randomized study determined the efficacy of adding peppermint essential oil to a cool wash cloth to ease nausea associated with chemotherapy.
Lower Dose Olanzapine Plus Triplet Antiemetic Therapy May Reduce Chemotherapy-Induced Nausea and Vomiting
Olanzapine added to triplet antiemetic therapy, has been shown to reduce risk of chemotherapy-induced nausea and vomiting, but can cause daytime sleepiness.
Cinvanti Single-Dose Regimen Approved for Patients Receiving Moderately Emetogenic Chemotherapy
Cinvanti injectable emulsion can be administered as a 2-minute intravenous injection or 30-minute intravenous infusion.
Data on Corticosteroid-Related Adverse Events in Advanced Cancer Are Lacking, Needed
Although corticosteroids are frequently used to manage adverse effects (AEs), data on AEs related to these agents are lacking. Therefore, these researchers sought to determine if better reporting of corticosteroid-related AEs would be of benefit.
Radiotherapy-Induced Nausea, Vomiting Affect QOL for Patients, Caregivers Differently
Outcomes assessment of patients participating in several different trials quantified the effect of nausea and vomiting separately, and on both the patient and the caregiver.
Moderately Emetogenic Chemotherapy Drug Demonstrates High Emetogenic Potential
Based on results of a prospective and retrospective study evaluating emetogenic potential of 50 chemotherapeutic regimens, researchers suggest changing the classification of irinotecan.
- Loading...
Loading...
Next post in Side-Effect Management
Loading... 
Loading...